Atrial Fibrillation Market

Atrial Fibrillation Market - Global Industry
Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026, GE Healthcare
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and
abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer
symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and
shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke,
and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated with
atrial fibrillation include valvular heart disease such as coronary artery disease, heart failure,
congenital heart disease, and cardiomyopathy as well as high blood pressure. Valvular heart
disease majorly occurs due to rheumatic fever, while high alcohol intake, thyrotoxicosis, and
diabetes mellitus are other causes. The pulse and post-pulse measurement, via electrocardiogram
(ECG) help in the diagnosis of the disease.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/205
According to CDC, 2.7–6.1 million individuals in the U.S. alone suffer from atrial fibrillation
and this number is projected to increase with the growing aging population in this country.
Around 2% of the population below 65 years of age suffers from AF. However, around 9% of
the population aged 65 years and above suffers from AF. The global market for atrial
fibrillation is expected to witness significant growth, owing to rising prevalence of AF, primarily
due to the rising number of health cases such as diabetes, obesity, and hypertension. The
geriatric population is more susceptible to this condition due to their weak immune system.
Rising adoption of catheter ablation procedures is expected to fuel growth of the atrial
fibrillation market over the forecast period (2016–2024).
Atrial Fibrillation Market Taxonomy
On the basis of treatment type, the global market is segmented into:
Non-pharmacological
MAZE Surgery
Catheter Ablation
Electric Cardioversion
Pharmacological
On the basis of device type, the market is segmented into:
Catheter Ablation Devices
Mapping and Recording Systems
Access Devices
Cardiac Monitors
Intracardiac Echocardiography (ICE) Systems
Left Atrial Appendage (LAA) and Closure Devices
Report includes chapters which deeply display the following deliverable about industry :
• Atrial Fibrillation Market Research Objective and Assumption
• Atrial Fibrillation Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Atrial Fibrillation Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Atrial Fibrillation Market, By Regions
• Atrial Fibrillation Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Atrial Fibrillation Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Atrial Fibrillation Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Atrial Fibrillation Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Rising prevalence of atrial fibrillation, especially among the geriatric population to drive growth
of the atrial fibrillation market
AF increases the life expectancy of a patient, thus the demand for atrial fibrillation is increasing
for treatment of the geriatric population. Growing adoption of catheter ablation and
advancements in technology are expected to fuel growth of the market for atrial fibrillation.
However, lack of skilled professionals and alternative options over AF healing devices are
projected to hamper growth of the atrial fibrillation market. According to the National Center
for Biotechnology Information (NCBI), the prevalence of AF is estimated to double in a span of
two decades (2010–2030). Several government initiatives are working towards making AF more
accessible to the general populace. For instance, favorable regulatory steps such as ‘National
Programme for Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPDCS)’
undertaken by the Government of India, which aims to prevent and control premature mortality
and morbidity from cardiovascular diseases, stroke, and diabetes mellitus. This I turn, is
expected to propel growth of the market during the forecast period.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/205
North America holds a dominant position in the market, accounting for the largest market
share. The dominance of the market in the region is attributed to high presence of advanced
healthcare facilities and higher adoption of technologically advanced devices and treatment
measures such as AF in countries such as U.S. and Canada, in the region. The market in Asia
Pacific is projected to witness substantial growth in the near future, owing to the growing
population in the region and rapidly aging population, who are highly vulnerable to heart
diseases. Also, demand for atrial fibrillation treatment devices is estimated to increase, owing to
the advancements in healthcare infrastructure and rise in expenditure in the emerging
economies such as China and India thereby, fueling market growth over the forecast period.
Some of the major companies operating in the atrial fibrillation market are Cardiofocus, Inc.,
Biosense Webster, Inc., Biotitic Se & Co. Kg, St. Jude Medical, Inc., Medtronic, Inc., Carima,
Inc., Boston Scientific Corporation, Ncontact, Inc., and Agricore, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart.

Download Report